As of December 2024, Madrigal Pharmaceuticals has a market cap of $4.60B. This makes Madrigal Pharmaceuticals the world's 2957th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.36B | -4.62% |
2023 | $4.57B | -20.28% |
2022 | $5.73B | 242.52% |
2021 | $1.67B | -23.77% |
2020 | $2.19B | 22.02% |
2019 | $1.80B | -19.17% |
2018 | $2.23B | 22.80% |
2017 | $1.81B | 516.04% |
2016 | $294.16M | 21.63% |
2015 | $241.85M | -86.79% |
2014 | $1.83B | -49.43% |
2013 | $3.62B | -41.91% |
2012 | $6.23B | 93.15% |
2011 | $3.23B | -23.69% |
2010 | $4.23B | 20.95% |
2009 | $3.50B | -17.32% |
2008 | $4.23B | -8.66% |
2007 | $4.63B | - |